Paloma Partners’s Orthofix Medical OFIX Stock Holding History

Paloma Partners’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,618	Closed	-$244K	–	2180
2019 Q2	$244K	Buy	+4,618	New	+$246K	﹤0.01%	1420
2018 Q2	–	Sell	-6,997	Closed	-$411K	–	2039
2018 Q1	$411K	Buy	+6,997	New	+$392K	0.01%	1478

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Paloma Partners's OFIX Position: Q3 2019 in Review

Paloma Partners sold out of Orthofix Medical (OFIX) in Q3 2019, closing a stake of 4,618 shares — an estimated $244K sold.

Paloma Partners first reported a position in OFIX in Q1 2018 and held it in 2 quarters. The position peaked at $411K in Q1 2018. 158 funds tracked by Wall St. Rank hold OFIX as of Q3 2019.

Paloma Partners reported no remaining Orthofix Medical position as of Q3 2019 after selling out during the quarter.
Paloma Partners sold 4,618 Orthofix Medical shares in Q3 2019, an estimated $244K.
Paloma Partners first reported a position in Orthofix Medical in Q1 2018 and held it in 2 quarters.
Paloma Partners's Orthofix Medical position peaked at $411K in Q1 2018.
158 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.